Literature DB >> 17869221

Analysis of p53-RNA interactions in cultured human cells.

Kasandra J-L Riley1, L James Maher.   

Abstract

Tumor suppressor p53 is a well-characterized transcription factor that binds DNA. More enigmatic are the RNA-binding properties of p53 and their physiological relevance. We used three sensitive co-immunoprecipitation methods in an attempt to detect RNAs that tightly associate with p53 in cultured human cells. Although recombinant p53 protein binds RNA in a sequence-nonspecific mode, we do not detect specific in vivo RNA binding by p53. These results suggest that RNA binding is prevented by post-translational p53 modifications. A ribonucleoprotein (not p53) is purified by multiple IgG monoclonal antibodies (including anti-p53 antibodies) from both p53 +/+ and p53 null cells. Caution is therefore required in interpreting RNA co-immunoprecipitation experiments. Though not formally excluded, these results do not support models in which p53 binds specific RNA partners in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869221      PMCID: PMC2211410          DOI: 10.1016/j.bbrc.2007.08.181

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo.

Authors:  Somashe Niranjanakumari; Erika Lasda; Robert Brazas; Mariano A Garcia-Blanco
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

Review 2.  RNA-protein interactions.

Authors:  Kathleen B Hall
Journal:  Curr Opin Struct Biol       Date:  2002-06       Impact factor: 6.809

3.  Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.

Authors:  Yoichiro Yoshida; Hiroto Izumi; Takayuki Torigoe; Hiroshi Ishiguchi; Takeshi Yoshida; Hideaki Itoh; Kimitoshi Kohno
Journal:  Oncogene       Date:  2004-05-27       Impact factor: 9.867

Review 4.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

5.  p53 binds selectively to the 5' untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4.

Authors:  S J Miller; T Suthiphongchai; G P Zambetti; M E Ewen
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA.

Authors:  Yoichiro Yoshida; Hiroto Izumi; Takayuki Torigoe; Hiroshi Ishiguchi; Hideaki Itoh; Dongchon Kang; Kimitoshi Kohno
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

7.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

8.  CLIP identifies Nova-regulated RNA networks in the brain.

Authors:  Jernej Ule; Kirk B Jensen; Matteo Ruggiu; Aldo Mele; Aljaz Ule; Robert B Darnell
Journal:  Science       Date:  2003-11-14       Impact factor: 47.728

9.  iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.

Authors:  Daniele Bergamaschi; Yardena Samuels; Nigel J O'Neil; Giuseppe Trigiante; Tim Crook; Jung-Kuang Hsieh; Daniel J O'Connor; Shan Zhong; Isabelle Campargue; Matthew L Tomlinson; Patricia E Kuwabara; Xin Lu
Journal:  Nat Genet       Date:  2003-01-13       Impact factor: 38.330

10.  A global suppressor motif for p53 cancer mutants.

Authors:  Timothy E Baroni; Ting Wang; Hua Qian; Lawrence R Dearth; Lan N Truong; Jue Zeng; Alec E Denes; Stephanie W Chen; Rainer K Brachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

View more
  4 in total

Review 1.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

Review 2.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

3.  Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Authors:  Yuan Shen; Shanshan Liu; Jiao Fan; Yinghua Jin; Baolei Tian; Xiaofei Zheng; Hanjiang Fu
Journal:  EMBO Rep       Date:  2017-03-06       Impact factor: 8.807

4.  Cooperativity dominates the genomic organization of p53-response elements: a mechanistic view.

Authors:  Yongping Pan; Ruth Nussinov
Journal:  PLoS Comput Biol       Date:  2009-07-24       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.